Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., which is listed only as a subsidiary in the exhibit index) for the reporting period ending November 30, 2018. The filing discloses a material acquisition and a significant amendment to the company's credit facilities.
Key Financial Metrics and Agreements
- Acquisition Consideration: Landec acquired Yucatan Foods, L.P. and Camden Fruit Corporation for a total initial consideration of $80.0 million, comprised of $60.0 million in cash and $20.0 million in Landec common stock.
- Stock Consideration Terms: The $20.0 million stock portion is subject to lock-up provisions: 50% released on the 3-year anniversary and the remaining 50% on the 4-year anniversary.
- Indemnity Structure: Recovery for indemnity claims is limited first to the Stock Consideration held by Camden stockholders, and subsequently to the cash received by Yucatan limited partners.
- Debt Facility Expansion: The credit facility was increased by $55.0 million.
- Revolving Line of Credit: Increased from $100.0 million to $105.0 million.
- Term Loan: Increased from $50.0 million to $100.0 million.
- Debt Service: The Amended Term Loan requires quarterly payments of $2.5 million, with the remainder due at maturity on September 23, 2021.
- Interest Rates: Based on the Total Leverage Ratio, rates are Prime + 0.25% to 2.25% or Eurodollar + 1.25% to 3.25%.
- Leverage Covenant: The agreement allows a Total Leverage Ratio of up to 4.50 to 1.00.
- Accordion Feature: Landec retains the right to increase commitments by up to an additional $10.0 million.
Material Changes Versus Prior Period
The primary material change is the expansion of the company's debt capacity to fund the acquisition of Yucatan Foods. The credit facility's total capacity increased from $150.0 million to $205.0 million. Additionally, the company's capital structure changed due to the issuance of $20.0 million in equity as part of the acquisition consideration.
Outlook, Risks, and Contingencies
- Purpose of Financing: The credit amendment was executed primarily to fund the Yucatan Foods acquisition, pay related fees, and for general corporate purposes.
- Collateral: The facility is secured by substantially all personal property assets of Landec and its subsidiaries, with the exception of Apio's equity interest in Windset Holdings 2010 Ltd.
- Risks: The agreement contains customary events of default that could trigger acceleration of obligations or increased interest rates. The company's ability to service the debt is tied to its Total Leverage Ratio.
- Unusual Items: The filing notes that the stock consideration is locked up for 3 to 4 years, which may impact the liquidity of the sellers but does not directly impact Landec's immediate cash flow beyond the initial $60 million outlay.
Investor Verification Checklist
- Verify the exact cash outflow of $60.0 million and its impact on current liquidity ratios.
- Confirm the integration timeline and expected revenue contribution of Yucatan Foods and Camden Fruit Corporation.
- Review the full text of the Credit Amendment (Exhibit 10.1) for specific definitions of "Total Leverage Ratio" and potential covenant traps.
- Assess the impact of the increased quarterly debt service ($2.5 million) on future free cash flow.
- Clarify the role of Lifecore Biomedical, Inc. as a subsidiary guarantor within the amended credit facility.